KWKevin I. Watt

Kevin I. Watt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kevin I. Watt has a total of 234 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessing the capacity of available pharmaceuticals to protect human PSC-derived cardiomyocytes from anthracycline cardiotoxicity

    by Stephanie R. Hyslop, Julian Stolper, Yi Sing Gee, Mitch Mathiew, Kathy Karavendzas, Jacob Smith, Dad Abu-Bonsrah, Jennii Luu, Robert Vary, Karla J Cowley, et al.

  • Open Access

    Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP

    by Nazli Robin, Nicole G. Barra, Kevin P. Foley, Yujin E. Li, Akhilesh K. Tamrakar, Danish Patoli, Irena A. Rebalka, Tabitha Cree, Kaitlyn Bibby, Khang Nguyen, et al.

    Statin intolerance and side effects such as low-level myopathy limit statin use and the dose for optimal cholesterol lowering. We found that priming the NLRP3 inflammasome with bacterial components like lipopolysaccharide lowered the dose of statins that caused side effects in muscle cells. We then built models of low-level statin myopathy and found that muscle cell–autonomous statin-induced myopathy occurs through the NLRP3 inflammasome in vitro and in mice. Statin-induced muscle cell death and higher Atrogin-1 were prevented by blocking NLRP3 or restoring isoprenoids but not cholesterol. Statins reduced glycolysis in muscle cells, which required lower protein prenylation. Statins lowered YAP effector genes and promoted nuclear accumulation of FOXO. Activating YAP, restoring isoprenoids, or blocking NLRP3 mitigated nuclear FOXO accumulation, statin-induced muscle atrophy, and statin-mediated lowering of protein synthesis. These results define a statin-induced myopathy pathway where metabolic danger engages the NLRP3 inflammasome and YAP via lower prenylation independent of cholesterol.


  • Open Access

    Proteomics Uncovers Cryptic JPH2 Loss in Paediatric Dilated Cardiomyopathy

    by Carlos C. Smith-Diaz, Valerii Iaprintsev, Hannah Huckstep, Ivan Macciocca, Adam T. Piers, Natasha Henden, Samantha Bryen, Natalie Stewart, Alexandra Butters, Amy M. Baker, et al.

    Despite recent advances in next-generation sequencing, genetic diagnostic rates for dilated cardiomyopathy (DCM) remain low. Among paediatric DCM, causes are often heritable, with a greater frequency of de novo , recessive and syndromic causes of disease. Novel diagnostic methods are therefore required to solve monogenic cases. To assess the value of proteomics as a diagnostic tool for paediatric DCM, we obtained left ventricle myocardial samples from paediatric patients undergoing heart transplantation at the Royal Children’s Hospital, Melbourne. We performed genome sequencing and proteomics and leveraged this multi-omics dataset to uncover the molecular cause of disease in a gene elusive proband. The proband carried a heterozygous JPH2 frameshift variant identified on clinical exome sequencing. However, proteomic analysis showed a pronounced downregulation of JPH2, suggestive of biallelic loss-of-function. Closer inspection of the genomic data revealed a large inversion (∼8.34 Mb) with a breakpoint falling within intron 5 of JPH2 that displaces the 3′UTR from the coding transcript. The two variants were confirmed to be in trans using long read DNA sequencing, consistent with a diagnosis of JPH2 autosomal recessive DCM. Finally, we applied RNA sequencing with total RNA library preparation to show that transcripts containing a 3′UTR were reduced to ∼10% relative to controls. As a proof-of-principle, we present the first reported use of proteomics from explanted cardiac tissue to provide a genetic diagnosis. Our methodology has broad relevance to patients with genetically unsolved Mendelian diseases, who might undergo organ transplantation as part of clinical management.

  • Open Access

    Automated Integration of Multi-Slice Spatial Transcriptomics Data in 2D and 3D

    by Denis Bienroth, Natalie Charitakis, Dillon Wong, Sabrina Jaeger-Honz, Dimitar Garkov, Kevin I. Watt, Julian Stolper, Hazel Chambers-Smith, Duncan MacGregor, Bronwyn Christiansen, et al.

    The field of spatial transcriptomics is rapidly evolving, with increasing sample complexity, resolution, and tissue size. Yet the field lacks comprehensive solutions for automated integration and analysis of multi-slice data in either stacked (3D) or co-planar (2D) formation. To address this, we developed VR-Omics, a free, platform-agnostic software that distinctively provides end-to-end automated processing of multi-slice data through a biologist-friendly interface. Benchmarking against existing methods demonstrates VR-Omics’ unique strengths to perform comprehensive end-to-end analysis of multi-slice stacked data. Applied to rare paediatric cardiac rhabdomyomas, VR-Omics uncovered previously undetected dysregulated metabolic networks through co-planar slice analysis, demonstrating its potential for biological discoveries.


  • Top Cited Papers

    Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia

    by Roberta Sartori, Adam Hagg, Sandra Zampieri, Andrea Armani, Catherine E. Winbanks, Laís R. Viana, Mouna Haidar, Kevin I. Watt, Hongwei Qian, Camilla Pezzini, et al.

    Neuromuscular junction remodeling and deterioration due to impaired BMP signaling are associated with cancer-induced muscle wasting.


  • Open Access

    Sex-Specific Control of Human Heart Maturation by the Progesterone Receptor

    by Choon Boon Sim, Belinda Phipson, Mark Ziemann, Haloom Rafehi, Richard J. Mills, Kevin I. Watt, Kwaku D. Abu-Bonsrah, Ravi K.R. Kalathur, Holly K. Voges, Doan T. Dinh, et al.

    Background: Despite in-depth knowledge of the molecular mechanisms controlling embryonic heart development, little is known about the signals governing postnatal maturation of the human heart. Methods: Single nucleus RNA-sequencing (snRNA-seq) of 54,140 nuclei from 9 human donors was used to profile transcriptional changes in diverse cardiac cell types during maturation from fetal stages to adulthood. Bulk RNA-sequencing and the assay for transposase-accessible chromatin using sequencing (ATAC-seq) were used to further validate transcriptional changes and to profile alterations in the chromatin accessibility landscape in purified cardiomyocyte nuclei from 21 human donors. Functional validation studies of sex steroids implicated in cardiac maturation were performed in human pluripotent stem cell-derived cardiac organoids and mice. Results: Our data identify the progesterone receptor as a key mediator of sex-dependent transcriptional programs during cardiomyocyte maturation. Functional validation studies in human cardiac organoids and mice demonstrate the progesterone receptor drives sex-specific metabolic programs and maturation of cardiac contractile properties. Conclusions: These data provide a blueprint for understanding human heart maturation in both sexes and reveal an important role for the progesterone receptor in human heart development.


  • Open Access

    Integrated Glycoproteomics Identifies a Role of N-Glycosylation and Galectin-1 on Myogenesis and Muscle Development

    by Ronnie Blazev, Christopher Ashwood, Jodie L. Abrahams, Long H. Chung, Deanne Francis, Pengyi Yang, Kevin I. Watt, Hongwei Qian, Gregory A. Quaife-Ryan, James E. Hudson, et al.


  • Treatment of type 2 diabetes with the designer cytokine IC7Fc

    by Maria Findeisen, Tamara L. Allen, Darren C. Henstridge, Helene Kammoun, Amanda E. Brandon, Laurie L. Baggio, Kevin I. Watt, Martin Pal, Lena Cron, Emma Estevez, et al.

    The gp130 receptor cytokines IL-6 and CNTF improve metabolic homeostasis but have limited therapeutic use for the treatment of type 2 diabetes. Accordingly, we engineered the gp130 ligand IC7Fc, in which one gp130-binding site is removed from IL-6 and replaced with the LIF-receptor-binding site from CNTF, fused with the Fc domain of immunoglobulin G, creating a cytokine with CNTF-like, but IL-6-receptor-dependent, signalling. Here we show that IC7Fc improves glucose tolerance and hyperglycaemia and prevents weight gain and liver steatosis in mice. In addition, IC7Fc either increases, or prevents the loss of, skeletal muscle mass by activation of the transcriptional regulator YAP1. In human-cell-based assays, and in non-human primates, IC7Fc treatment results in no signs of inflammation or immunogenicity. Thus, IC7Fc is a realistic next-generation biological agent for the treatment of type 2 diabetes and muscle atrophy, disorders that are currently pandemic.


  • The Hippo Signaling Pathway in the Regulation of Skeletal Muscle Mass and Function

    by Kevin I. Watt, Craig A. Goodman, Troy A. Hornberger, Paul Gregorevic

    The Hippo signaling pathway regulates the activity of the proteins Yes-associated protein (Yap) and transcriptional co-activator with PDZ-binding motif (Taz) to control tissue growth in many different cell types. Previously, we demonstrated that Yap is a critical regulator of skeletal muscle mass. We hypothesize that alterations in Yap and Taz activity modulate the anabolic adaptations of skeletal muscle to resistance exercise.


  • Top Cited Papers

    Extracellular Vesicles Provide a Means for Tissue Crosstalk during Exercise

    by Martin Whitham, Benjamin L. Parker, Martin Friedrichsen, Janne R. Hingst, Marit Hjorth, William E. Hughes, Casey L. Egan, Lena Cron, Kevin I. Watt, Rhiannon P. Kuchel, et al.